Breaking News

Danaher to buy Pall Corporation for $14bn

By Dan Stanton contact

- Last updated on GMT

Danaher to buy Pall Corporation for $14bn
Pall has agreed to be acquired by Danaher Corporation for $13.8bn (€12bn).

Yesterday this publication reported rumours that Pall Corporation was being eyed up by Thermo Fisher and Danaher.

The filtration, separation and purification tech firm is set to be incorporated into Danaher after the company agreed this morning to be acquired for $127.20 per share in cash.

Pall CEO Larry Kingsley said the transaction created an “opportunity for long-term growth”​ and that his company is a complementary fit for Danaher.

“Danaher's proven management system and strong financial position coupled with Pall's expertise, brand and channel strength in the field of filtration and separation science [will enable] the creation of tremendous value for the global customers of the combined company.”

Yesterday, this publication reported​ Danaher had entered a bidding war with Thermo Fisher, with several analysts saying the firm was highly attractive to both, though Pall’s biopharma assets were deemed more of an obvious fit for Thermo Fisher.

The transaction is expected to close around the end of the year.

On the back of this deal, Danaher has said it intends to split into two independent, publicly traded companies: A science and technology growth company which will include the Pall business and will retain the Danaher name, and a diversified industrial growth company.

"The pending strategic acquisition of Pall Corporation announced today offers us the unique opportunity to drive greater shareholder value going forward as two stronger and better companies,"​ said Danaher CEO Thomas Joyce, adding "each company will be more focused with access to the capital necessary to pursue organic and inorganic growth opportunities."

Related news

Show more

Related products

show more

Protect your bulk filtration and dispense step

Protect your bulk filtration and dispense step

Parker Bioscience Filtration | 20-Jan-2020 | Data Sheet

Does your process need greater protection when the value of your product is at its highest?

At the bulk filtration and container fill stage,...

Removing Aggregates of an Acidic Monoclonal Antibody

Removing Aggregates of an Acidic Monoclonal Antibody

Bio-Rad Laboratories | 22-Oct-2018 | Technical / White Paper

CHT Ceramic Hydroxyapatite Media/Resins are known as the industry gold standard for
impurity removal during monoclonal antibody (mAb) purification....

Downstream Purification of Large Biomolecules

Downstream Purification of Large Biomolecules

Bio-Rad Laboratories | 17-Sep-2018 | Research Study

Our newest strong anion exchange resin provides both high binding capacity and
high recovery, even at high flow rates. A rigid bead complete with...


Inline concentration improves process economics

Pall Biotech | 15-Jun-2018 | Case Study

Would you like to enhance your downstream process, increase production capacity and reduce costs? This case study application note demonstrates how implementing...

Follow us


View more